πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 635 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7615566

Substituted pyrrolidine and related compounds

Theravance, Inc. Β· Granted Tue Nov 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7612037

Cross-linked glycopeptide-cephalosporin antibiotics

Theravance, Inc. Β· Granted Tue Nov 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7604944

Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, n

Theravance, Inc. Β· Granted Tue Oct 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7601690

Cross-linked glycopeptide-cephalosporin antibiotics

Theravance, Inc. Β· Granted Tue Oct 13 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7592355

Quinolinone-carboxamide compounds as 5-HT, receptor agonists

Theravance, Inc. Β· Granted Tue Sep 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7585653

Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, n

Theravance, Inc. Β· Granted Tue Sep 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7585879

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Sep 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7582765

Aryl aniline Ξ²2 adrenergic receptor agonists

Theravance, Inc. Β· Granted Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7572918

Process for preparing substituted 4-amino-1-(pyridylmethyl)piperidine and related compound

Theravance, Inc. Β· Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7569588

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Aug 04 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7569586

Compounds having Ξ²2 adrenergic receptor agonist and muscarinic receptor antagonist activit

Theravance, Inc. Β· Granted Tue Aug 04 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7566785

Amidine substituted aryl aniline compounds

Theravance, Inc. Β· Granted Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7560469

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Jul 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7557247

Crystalline form of Ξ²2 adrenergic receptor agonist

Theravance, Inc. Β· Granted Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7557126

Diphenylmethyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7553962

Cross-linked glycopeptide-cephalosporin antibiotics

Theravance, Inc. Β· Granted Tue Jun 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7553971

Aryl aniline Ξ²2 adrenergic receptor agonists

Theravance, Inc. Β· Granted Tue Jun 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7550595

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Jun 23 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 18 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7544364

Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin

Theravance, Inc. Β· Granted Tue Jun 09 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 04 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7534889

5-HT4 receptor agonist compounds

Theravance, Inc. Β· Granted Tue May 19 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 14 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7531623

Hydrochloride salts of a glycopeptide phosphonate derivative

Theravance, Inc. Β· Granted Tue May 12 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7528253

Compounds having Ξ²2 adrenergic receptor agonist and muscarinic receptor antagonist activit

Theravance, Inc. Β· Granted Tue May 05 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7524959

Biphenyl derivatives

Theravance, Inc. Β· Granted Tue Apr 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7524965

Dialkylphenyl compounds having Ξ²2 adrenergic receptor agonist and muscarinic receptor anta

Theravance, Inc. Β· Granted Tue Apr 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted